Latest Psychedelic startups Podcast Episodes
Transcranial magnetic stimulation (TMS) paired with ketamine: inside a clinic offering a frontier treatment
Business Trip - November 29, 2022 16:00 - 50 minutesIn this new episode of Business Trip, we interview one of the first clinics to offer a protocol that includes TMS (transcranial magnetic stimulation) and ketamine infusion. TMS is a non-invasive procedure that sends electric currents to specific regions in the brain, including areas linked to d...
Perspectives from Christian Angermayer, investor and founder in psychedelics
Business Trip - October 27, 2022 19:00 - 42 minutesIn this week's episode, we chat with Christian Angermayer. Christian co-founded atai Life Sciences and was an early investor in Compass Pathways -- two of the first companies commercializing psychedelic medicine. Christian also launched a fund dedicated to mental and neurological health called r...
Soltara: an ethical and profitable ayahuasca retreat
Business Trip - September 14, 2022 23:00 - 54 minutesIn this week’s episode, we chat with Melissa Stangl, co-founder of Soltara Healing Center. Soltara is an ayahuasca retreat center whose ceremonies are lead by Shipibo healers, with locations in Peru and Costa Rica. The Shipibo people are from the Peruvian Amazon and are part of a tradition that ...
Microdosing (part 3): The path to FDA approval w/ MindMed and Diamond Therapeutics
Business Trip - August 16, 2022 16:00 - 58 minutesThis is final episode in our 3-part series on microdosing that explores the science, history, and clinical applications. In this episode, we discuss the path to FDA approval for microdosing. We chat with the chief medical officers from Diamond Therapeutics and MindMed about their microdosing c...
Microdosing (part 2): Placebo is a hell of a drug with Balázs Szigeti
Business Trip - August 10, 2022 19:00 - 37 minutesThis is part 2 or our 3 part series on microdosing that explore the science, history, and clinical applications. In part 1, we interviewed psychedelic researcher James Fadiman about the fundamentals of microdosing. In part 2, we wanted to understand the placebo effect. In particular, is it the...
Microdosing (part 2): The placebo effect with Balázs Szigeti
Business Trip - August 10, 2022 19:00 - 37 minutesThis is part 2 or our 3 part series on microdosing that explore the science, history, and clinical applications. In part 1, we interviewed psychedelic researcher James Fadiman about the fundamentals of microdosing. In part 2, we wanted to understand the placebo effect. In particular, is it the...
Microdosing (part 1): James Fadiman and the fundamentals of microdosing
Business Trip - August 03, 2022 15:00 - 33 minutesIn this 3-part series on microdosing, we explore the science, history, and its clinical potential. The anecdotal benefits of microdosing include better mood, creativity, and increased focus. But there are still many unanswered questions that remain. What is an effective dosing protocol? Is it ...
How the DEA and FDA will regulate psychedelic medicine
Business Trip - June 24, 2022 14:00 - 48 minutesIn this week’s episode, we chat with Matt Zorn, an attorney at Yetter Coleman with expertise in DEA law, especially regarding psychedelics. Matt is currently challenging the DEA’s decision to schedule 5 new tryptamines, he recently argued Kathryn Tucker’s psilocybin “Right To Try” case against t...
The state of psychedelics: Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House)
Business Trip - June 05, 2022 14:00 - 45 minutesIn this week’s special episode, Matias chats with Dr. Rachel Yehuda and Zach Haigney at Soho House in New York City. The episode was recorded in front of a live audience. Dr. Yehuda has spent the last 30 years doing research on PTSD and trauma and is leading the MDMA-assisted therapy research at...
Empowering the next wave of psychedelic therapists: Journey Clinical
Business Trip - May 23, 2022 04:00 - 41 minutesIn Episode 18, we chat with Jonathan Sabbagh and Myriam Barthes, the co-founders of Journey Clinical, a platform that enables licensed therapists to offer ketamine-assisted psychotherapy (KAP). Journey Clinical provides licensed therapists with an on-demand KAP-trained medical team, customized t...
Osmind and the future of electronic health records in psychedelic medicine
Business Trip - April 18, 2022 21:00 - 36 minutesIn today’s episode, we chat with Lucia Huang, the CEO and co-founder of Osmind, an electronic health record software system for treatment resistant mental health practices that is already in over 300 clinics. In this episode, we discuss: How Osmind makes data-driven decisions Osmind’s quick...
Palo Santo on investing in 2nd gen psychedelics and public markets
Business Trip - March 21, 2022 21:00 - 48 minutesIn today’s episode, we chat with Tim Schlidt, a partner at Palo Santo. Palo Santo is a fund investing in psychedelic therapeutics. Palo Santo’s portfolio includes companies like Eleusis, Tactogen, and Journey Clinical. In this episode, we discuss: Tim’s background in healthcare finance Invest...
Designing psychedelic mindstates, with Mindstate Design Labs
Business Trip - February 10, 2022 06:00 - 56 minutesToday’s episode features Dillan Dinardo and Tom Ray, the co-founders of Mindstate Design Labs. Mindstate has a unique framework to design psychedelic compounds using what they call the “primer probe method.” This method involves combining a known psychedelic with a non-psychedelic compound. Mind...
PsyMed Ventures, our $25M fund to invest in psychedelic medicine & mental health tech
Business Trip - January 10, 2022 06:00 - 43 minutesToday’s episode announces the launch of PsyMed Ventures, a $25M fund we started with Dina Burkitbayeva to invest in psychedelic medicine companies and mental health technologies. PsyMed Ventures is a community-focused fund and syndicate providing capital and support to companies revolutionizing ...
PsyMed Ventures, our venture fund to invest in psychedelic medicine & mental health tech
Business Trip - January 10, 2022 06:00 - 43 minutesToday’s episode announces the launch of PsyMed Ventures, a $25M fund we started with Dina Burkitbayeva to invest in psychedelic medicine companies and mental health technologies. PsyMed Ventures is a community-focused fund and syndicate providing capital and support to companies revolutionizing ...
MAPS PBC, rethinking the pharma business model and MDMA-assisted therapy
Business Trip - November 24, 2021 06:00 - 51 minutesToday’s episode features Amy Emerson, the CEO of MAPS Public Benefit Corporation (PBC), which is a fully owned subsidiary of MAPS, and its purpose is to commercialize MDMA-assisted therapy. We discuss the MAPS PBC and it’s business model for MDMA-assisted therapy. In this episode, we discuss: ...
On transformational ketamine therapy and running an integrative psychedelic clinic
Business Trip - October 28, 2021 05:00 - 1 hourIn today’s episode, we discuss what it’s like being a psychologist who owns a psychedelic clinic. Genesee Herzberg is the co-founder of Sage Integrative Health, an integrative clinic in Berkeley, CA that offers ketamine-assisted therapy (KAP), psychotherapy, somatic therapy, and acupuncture. Gen...
The new frontiers of DMT therapies
Business Trip - October 06, 2021 20:00 - 42 minutesIn today’s episode, we explore the therapeutic application of DMT across a range of diseases and conditions including Alzheimer’s, stroke, and organ transplants. While much of the attention in psychedelic medicine has been on their ability to address neuropsychiatric indications, research sugges...
Scaling Psilocybin Therapy: Compass Pathways' Lars Wilde
Business Trip - August 13, 2021 17:00 - 59 minutesEpisode 10 features Lars Wilde, co-founder and Chief Business Officer of Compass Pathways, a mental health company with an initial focus on psilocybin therapy for Treatment-Resistant Depression. In this episode, we discuss: Lars’ experience overcoming Treatment-Resistant Depression with psiloc...
Scaling Psilocybin Therapy: Compass Pathways' Lars Wilde
Business Trip - August 13, 2021 17:00 - 59 minutesEpisode 10 features Lars Wilde, co-founder and Chief Business Officer of Compass Pathways, a mental health company with an initial focus on psilocybin therapy for Treatment-Resistant Depression. In this episode, we discuss: Lars’ experience overcoming Treatment-Resistant Depression with psiloc...
Analyzing the atai Life Sciences IPO
Business Trip - June 10, 2021 01:00 - 50 minutesToday's episode features three experts, Josh Hardman, Michael Haichin, and Graham Pechenik as they analyze atai’s S-1 in advance of their IPO. In this episode, we discuss: How atai went from idea to IPO in 3 years An overview of atai’s drug development programs and enabling technologies The...
A 30 year journey towards ibogaine approval: Deborah Mash, CEO of DemeRx
Business Trip - May 04, 2021 05:00 - 44 minutesToday's episode features Deborah Mash, founder and CEO of DemeRx, a clinical stage company developing ibogaine therapies to treat substance use disorders. In this episode, we discuss: The science, experience and the safety behind Ibogaine’s “neurochemical reset” Navigating US drug regulatory ...
Clinical trials, media, reciprocity, open science: Founder of The Trip Report, Zach Haigney
Business Trip - March 16, 2021 21:00 - 21 minutesToday's episode features Zach Haigney, creator of The Trip Report, a newsletter about psychedelics, policy and business. In 2019, Zach started writing The Trip Report and quickly grew his readership by analyzing psychedelic news headlines from every angle. He’s able to break through all the noi...
How to (legally) make psychedelic medicine: CEO of Psygen, Danny Motyka
Business Trip - February 24, 2021 16:00 - 30 minutesToday's episode features Danny Motyka, founder of Psygen, a Canadian manufacturer of psychedelics, like MDMA, LSD, DMT, and synthetic psilocybin. Psygen makes pharmaceutical grade psychedelic medicines for clinical research and therapeutic applications. They have a license to be one of the firs...
From serving medicine to company founder: NANA founder Flor Bollini
Business Trip - January 05, 2021 02:00 - 33 minutesToday's episode features Flor Bollini, founder of NANA, an online platform that guides patients on using psychedelic medicine for holistic healing. NANA provides personalized protocols based on an assessment of your mental, emotional and physical health. From there you are partnered with a Nana...
Helping psychedelic practitioners through software: Maya Health CEO David Champion
Business Trip - October 19, 2020 06:00 - 29 minutesToday's episode features David Champion, CEO and co-founder of Maya, a software platform that helps practitioners and clinics manage psychedelic-assisted therapy practices. The data collected from treatments will help psychedelic stakeholders, from researchers to pharmaceutical companies, discov...
How to invest in psychedelic companies: Vine Ventures' Founder Ryan Zurrer
Business Trip - September 17, 2020 06:00 - 57 minutesToday's episode features Ryan Zurrer, founder of Vine Ventures, one of the first venture capital funds investing in psychedelic medicine. Ryan has deep roots in psychedelics culture and understands the many cultures within the psychedelic space. His fund is aligned with those values. If you’re ...
Vine Ventures' Founder Ryan Zurrer: How to invest in psychedelic companies
Business Trip - September 17, 2020 06:00 - 56 minutesToday's episode features Ryan Zurrer, founder of Vine Ventures, one of the first venture capital funds investing in psychedelic medicine. Ryan has deep roots in psychedelics culture and understands the many cultures within the psychedelic space. His fund is aligned with those values. If you’re ...
DoubleBlind's Shelby Hartman and Madison Margolin: Building a psychedelic media company
Business Trip - August 13, 2020 16:00 - 26 minutesToday’s episode features Shelby Hartman and Madison Margolin from DoubleBlind, a psychedelic magazine and media company founded in 2019 covering timely, untold stories about the expansion of psychedelics around the globe. Focused on how the industry can engage in sacred reciprocity and ethical p...
Building a psychedelic media company: DoubleBlind's Shelby Hartman and Madison Margolin
Business Trip - August 13, 2020 16:00 - 26 minutesToday’s episode features Shelby Hartman and Madison Margolin from DoubleBlind, a psychedelic magazine and media company founded in 2019 covering timely, untold stories about the expansion of psychedelics around the globe. Focused on how the industry can engage in sacred reciprocity and ethical p...
Related Psychedelic startups Topics